Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis
Abstract Aims Treatment for visceral leishmaniasis (VL) is hampered by the toxicity and/or high cost of drugs, as well as by emergence of parasite resistance. Therefore, there is an urgent need for new antileishmanial agents. Methods and Results In this study, the antileishmanial activity of a dipre...
Veröffentlicht in: | Parasite Immunology. - 42(2020), 12 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Online-Aufsatz |
Veröffentlicht: |
2020
|
Zugriff auf das übergeordnete Werk: | Parasite Immunology |
Umfang: | 14 |